Feb. 16, 2026
New Book Provides Practical Framework for Leading Multigenerational Healthcare Teams
Genfluence by Dan Collard and Katherine A. Meese, PhD offers strategies to bridge generational divides and leverage diverse strengths.
Feb. 16, 2026
Longeveron Appoints New CEO to Lead Pivotal Clinical Trials
Stephen H. Willard brings extensive biotech leadership experience to guide company's stem cell therapy programs
Feb. 16, 2026
Rhode Island Law Protects Independent Pharmacies from Surprise PBM Audits
A new state law caps on-site audits and gives the Attorney General power to enforce pharmacy audit rules
Feb. 16, 2026
Marcus & Millichap Closes Sale of Fort Worth Medical Office Center
The multi-tenant Overton Park Professional Center was sold to a New York-based 1031-exchange buyer.
Feb. 15, 2026
Eli Lilly Delivers Positive Clinical Outcomes Across Diverse Pipeline
The pharmaceutical leader reports strong performance beyond its weight-loss drug portfolio.
Feb. 15, 2026
CommonSpirit Reports Q2 2026 Financials: Revenue Up, Operating Income Down
Healthcare system navigates rising costs and workforce challenges, shifts revenue cycle management strategy.
Feb. 15, 2026
Revecore Earns Sixth Consecutive Best in KLAS Award for Complex Claims Services
Record-setting KLAS recognition underscores Revecore's role in helping health systems navigate mounting reimbursement pressure and reclaim earned revenue
Feb. 15, 2026
Alnylam Pharmaceuticals Turns Profitable in Q4 2025
Biotech firm's strong financial results challenge bearish narratives
Feb. 15, 2026
Jury Finds Johnson & Johnson Liable in Baby Powder Cancer Case
Pennsylvania jury orders $250,000 payout to family of woman who died of ovarian cancer after using J&J talc products
Feb. 15, 2026
CommonSpirit Health Reports Q2 2026 Earnings
Revenue up, but operating income declines to 0% margin
Feb. 15, 2026
Pacific Retirement Services Appoints New CEO
Sloan Bentley to lead non-profit senior living organization based in Medford, Oregon
Feb. 14, 2026
Oric Pharmaceuticals Highlights 2025 Milestones, Plans Phase 3 Prostate Trial
Biotech firm outlines development priorities for lead oncology programs, including plans to start Phase 3 study for prostate cancer in first half of 2025.
Feb. 14, 2026
Oscar Health Reports Return to Profitability in 2026
Company cites membership growth, rate actions, and tech-driven cost savings as key drivers
Feb. 14, 2026
American Well Focuses on Platform, Cost Cuts in Transformation
Digital health company narrows strategy, divests non-core activities to drive toward positive cash flow in Q4 2026
Feb. 14, 2026
Maze Therapeutics Highlights Upcoming MZE829 Kidney Data, Maps Phase 2 Plans for MZE782
CEO Jason Coloma discusses the company's genetics-driven approach to drug development at Guggenheim's Emerging Biotech Summit.
Feb. 14, 2026
CommonSpirit Posts Breakeven Margin in Q2
Chicago-based health system reports flat operating income amid rising costs
Feb. 14, 2026
Matt James named VP of foundations for Marshall Health Network
James to lead philanthropic strategy and alignment across affiliated foundations
Feb. 14, 2026
Stewart Memorial Physical Therapy Receives $9,240 Donation From Charitable Trust
The gift from the Pringle Charitable Trust will be used to purchase new equipment for therapy services.
Feb. 14, 2026
Hospital Leader Abraham Bejil Joins Midland Development Corp. Board
Bejil brings healthcare and facilities expertise as MDC eyes aerospace and transparency.
Feb. 13, 2026
Philadelphia Jury Awards $250K Verdict Against J&J in Talc Lawsuit
Marks first plaintiffs' win in city's sprawling talc mass tort case against healthcare giant
